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Abstract
Background: Circadian clocks control daily rhythms including sleep-wake, hormone secretion, and metabolism. These
clocks are based on intracellular transcription-translation feedback loops that sustain daily oscillations of gene expression in
many cell types. Mammalian astrocytes display circadian rhythms in the expression of the clock genes Period1 (Per1) and
Period2 (Per2). However, a functional role for circadian oscillations in astrocytes is unknown. Because uptake of extrasynaptic
glutamate depends on the presence of Per2 in astrocytes, we asked whether glutamate uptake by glia is circadian.
Methodology/Principal Findings: We measured glutamate uptake, transcript and protein levels of the astrocyte-specific
glutamate transporter, Glast, and the expression of Per1 and Per2 from cultured cortical astrocytes and from explants of
somatosensory cortex. We found that glutamate uptake and Glast mRNA and protein expression were significantly reduced
in Clock/Clock, Per2- or NPAS2-deficient glia. Uptake was augmented when the medium was supplemented with dibutyryl-
cAMP or B27. Critically, glutamate uptake was not circadian in cortical astrocytes cultured from rats or mice or in cortical
slices from mice.
Conclusion/Significance: We conclude that glutamate uptake levels are modulated by CLOCK, PER2, NPAS2, and the
composition of the culture medium, and that uptake does not show circadian variations.
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Introduction
Circadian rhythmicity is observed at all levels of physiology
and behavior. In mammals, the molecular mechanism
responsible for the generation of circadian oscillations arises
from interacting transcription-translation feedback loops in-
volving a set of key clock genes [1,2]. The transcription factors
Clock and Bmal1 induce the expression of the Period and
Cryptochrome genes. Period and Cryptochrome gene products then
feed back to suppress CLOCK/BMAL1 activity, thus inhib-
iting their own transcription. These loops are expressed in
many cell types where they regulate rhythmicity in most
aspects of physiology [3]. For example, cortical astrocytes in
culture display circadian rhythms in the expression of the clock
genes Per1 and Per2 [4,5]and in extracellular ATP content [6].
The role of these molecular rhythms in glial function is
unknown.
Mutations in key clock genes disrupt overt circadian rhythms
and have been associated with phenotypes such as obesity,
decreased longevity, increased sensitivity to substances of abuse,
depression and other cognitive impairments [1,3,7]. For example,
the dominant-negative, antimorphic mutation in the Clock gene is
responsible for the gradual loss of locomotor rhythms of Clock/
Clock mice housed in constant darkness [8] and mania-like
behaviors [9]. Deletion of the basic helix-loop-helix PAS motif
in the neuronal PAS domain protein 2 (NPAS2) gene (an analog of
Clock) leads to subtle circadian locomotor deficits and disrupts
learning and memory and sleep architecture [10,11]. Loss of both
NPAS2 and CLOCK abolishes circadian rhythms in locomotion
[12] and in peripheral organs [13]. Null mutations of both the Per1
and Per2 genes (Per1
ldc and Per2
ldc) abolish circadian locomotor
rhythms [14].
The best evidence that glia participate in circadian behaviors
comes from Drosophila where activity of the glia-specific gene, ebony,
is required for normal circadian rhythms in locomotion [15]. In
mammals, one study has examined the role of circadian clock
genes in astrocyte physiology. Per2
Brdm1 mutant mice exhibit a
phenotype similar to human alcoholism with elevated extracellular
levels of glutamate in the brain, decreased glutamate uptake by
cortical astrocytes and reduced expression of the high-affinity
glutamate-aspartate transporter GLAST (EAAT1) [16]. Based on
these results, we hypothesized that GLAST-dependent glutamate
uptake by astrocytes is regulated by components of the molecular
circadian clock. To test this hypothesis, we measured glutamate
uptake in cultured astrocytes of different genotypes, in cortical
slices and across time. Our results show that glutamate uptake by
glia is regulated by the Per2, Clock and NPAS2 genes, but that it is
not circadian.
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The Clock and Per2 genes regulate glutamate uptake and
GLAST levels in glia
To confirm and expand the previous observation that the Per2
gene modulates glutamate uptake in glia [16], we measured
glutamate uptake in astrocytes cultured from mice of different
circadian genotypes. In agreement with [16], we found that the
lack of the Per2 gene (Per2
m) significantly reduced glutamate uptake
(Fig. 1A). Glutamate uptake in Per2
m glia was significantly lower
than wild type at all concentrations tested (F(1,28)=209.2,
p,0.0001). We also found that the homozygous Clock mutation
diminished astroglial glutamate uptake (Fig. 1B). Maximal uptake
velocity, Vmax, was significantly reduced in Clock/Clock compared
to homozygous PER2::LUC (+/+) astrocytes (13.061.1 vs.
21.462.3 nmol/min/mg respectively, p,0.01). Affinity of the
transporter, Km, was not affected. Lower uptake by Clock/Clock
astrocytes replicated in four independent experiments. These
results indicate that glutamate uptake depends on PER2 and
CLOCK expression.
We next tested whether the reduced glutamate uptake in Clock/
Clock astrocytes correlates with a reduction in the levels of the
glutamate transporter, Glast. We found using qRT-PCR that the
Clock/Clock mutation reduced Glast mRNA levels by 2.5-fold (61%
decrease, p,0.001, n=2 independent experiments performed in
triplicate). The Clock/Clock mutation also reduced GLAST protein
immunofluorescence by approximately 70% (p,0.0001, n=2
independent experiments performed in triplicate). In addition,
NPAS2-deficient, but not Per1
mPer2
m mutant, astrocytes showed
reduced GLAST immunofluorescence (50% decrease compared to
wild-type, F(2,4)=44, p,0.01, n=3 and 2 cultures, respectively).
These results indicated clock gene regulation of GLAST
expression which correlated with glutamate uptake (Fig. 2).
Glutamate uptake is not circadian in mouse and rat
cortical astrocytes. We tested whether glutamate uptake is
circadian in astrocytes cultured from wild-type and Clock/Clock
mice and from rats. We found that uptake was significantly lower
in Clock/Clock mutant glia compared to wild type (21.760.9 vs.
27.860.9 nmol/min/mg respectively, p,0.001), but that uptake
did not vary over time (Fig. 3A). Similar results were found in rat
and mouse astrocytes sampled every 4 h starting 12 h after
medium change (data not shown). Next, we measured glutamate
uptake in rat astrocytes as a function of time and of extracellular
glutamate concentration to determine whether circadian
modulation of glutamate uptake is dose-dependent. We found
that Vmax was higher 8 h after a medium change, but no evidence
for circadian modulation of maximal or half-maximal (Km) uptake
(Fig. 3B).
Modulation of clock gene expression in glia. We assayed
whether circadian rhythms in astroglia were affected by the
composition of the culture medium. We used two bioluminescent
reporters of Period expression. Bioluminescence driven by Per1::luc
reflects Per1 promoter activity (transcription) whereas
bioluminescence from PER2::LUC is a measure of PER2
protein levels (translation). We found that bioluminescence levels
and rhythm amplitude for both Per1::luc (rat cortical glia) and
Figure 1. Glutamate uptake depends on the Clock and Per2 genes. Dose–response curves for glutamate uptake were generated comparing
wild-type astrocyte cultures and either Clock/Clock or Per2
m mutant astrocytes. A, Glutamate uptake was significantly reduced in astrocytes derived
from Clock/Clock mutants compared to wild-type (+/+) glia (n=3 cultures per concentration, mean6SEM). B, Glutamate uptake was significantly
reduced in astrocytes derived from Per2
m mutants compared to wild-type (+/+) glia (n=3 per concentration, mean6SEM).
doi:10.1371/journal.pone.0007476.g001
Figure 2. Higher glutamate uptake is associated with higher
GLAST immunofluorescence. Scatter plot shows the relationship
between glutamate uptake and grayscale intensity of GLAST immuno-
fluorescence. Data normalized to wild type levels (wild type: n=7;
NPAS22/2:n=6 ;Per1
mPer2
m:n=4 ;Clock/Clock: n=2, mean6SEM).
doi:10.1371/journal.pone.0007476.g002
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B27, a serum-free culture supplement used to promote cell survival
[17] (Fig. 4A, 4B). Adding B27 (1X final concentration) to rat
cortical astrocyte cultures increased bioluminescence levels more
than four-fold (4.360.11, n=4) and peak-to-trough levels two-fold
(2.060.6, n=4) after 24 h of recording (Fig. 4A). Adding the same
concentration of B27 to mouse cortical astrocytes increased
bioluminescence levels 1.5 fold (n=2) and peak-to-trough levels
more than two-fold (2.4 fold, n=2, Fig. 4B). We hypothesized that
factors in B27 might elevate clock gene expression in glia through
cAMP, a strong regulator of circadian rhythmicity [18]. To test
this hypothesis, we recorded glial bioluminescence rhythms for rat
Per1::luc astrocytes in medium supplemented with 250 mM
dibutyryl-cAMP (dB-cAMP) for 10 days prior to and during
bioluminescence recording. We found that dB-cAMP increased
Per1::luc bioluminescence levels 1.6-fold (n=2) and peak-to-trough
amplitude two-fold (n=2) (Fig. 4C) and, consistent with previous
reports [19,20]induced stellation of glial processes (Fig. 4D). Thus,
B27 or dB-cAMP can enhance Period gene expression and rhythm
amplitude in cortical astrocytes.
Glutamate uptake depends on B27, and dB-cAMP, but not
circadian time. Because we found that B27 and dB-cAMP
increased circadian rhythmicity, we decided to test the hypothesis
that B27 and dB-cAMP can induce circadian rhythms in
glutamate uptake. We measured glutamate uptake in rat cortical
astrocytes at 8 h intervals following a full medium change.
Supplementing culture medium with B27 caused a significant
13% increase in glutamate uptake (p,0.05, Fig. 5A), but did not
induce rhythmicity in uptake. Similarly, addition of 250 mM
dB-cAMP increased glutamate import by an average of 39%
(Fig. 5B, p,0.0001), but did not induce glutamate uptake
rhythms. Finally, we performed qRT-PCR for the astrocyte-
specific glutamate transporter, Glast. In two independent
experiments, we failed to detect circadian variation in Glast
mRNA in mouse cortical astrocytes cultured in B27-supple-
mented media (experiment 1, F(6,8)=1.59,p.0.05; experiment 2,
F(6,14)=1.60,p.0.05).
Glutamate uptake is not circadian in cortical slices. To
test whether the presence of neurons is required for the induction
of rhythms in glutamate uptake, we measured uptake in mouse
cortical slices over two consecutive days, starting 36 h after in vitro
preparation. We measured at doses ranging from 1–25 mM
glutamate based on the recent report that extracellular
glutamate levels in the cortex fluctuate between 20–30 mM [21].
We found that uptake in cortical slices was augmented with higher
glutamate loads, was higher on the first than the second day in vitro
(F(1,34)=11.09, p,0.01) but not circadian at any dose or day in
vitro (Fig. 6 and Fig. 7).
Specificity of the glutamate uptake assay. We assessed
the specificity of our glutamate assay in rat astrocytes by three
independent methods (Fig. 8). We found that replacing NaCl with
LiCl in the uptake buffer reduced glutamate uptake by
approximately 75% regardless of whether the astrocytes were
cultured with or without dB-cAMP for 10 days (p,0.001 for both
conditions, Fig. 8A). Consistent with previous observations [22],
we also found that 100 mM trans-2,4-PDC, a high-affinity
glutamate transport inhibitor [22,23], reduced uptake of 1 mM
glutamate by 53% (p,0.01) for control and by 64% (p,0.00001)
for astrocytes cultured for 10 days with dB-cAMP (Fig. 8B).
Finally, we compared glutamate uptake between our astrocyte
cultures and cells immunonegative for the astrocytes-specific
markers glial fibrillary acidic protein (GFAP) and GLAST. We
found that our astrocyte cultures imported significantly more
glutamate at all doses tested (Fig. 8C). We conclude that the
glutamate uptake we measured in cultured cortical astrocytes was
mediated primarily by a high-affinity, sodium-dependent
glutamate transporter which was constitutively active across the
circadian day.
Discussion
We found that astrocytes in culture take up glutamate as a
function of two transcription factors (Clock and NPAS2) and one
transcriptional regulator (Per2) associated with circadian function.
We also found that addition of B27 or dB-cAMP to the culture
medium increased expression of the clock genes, Period1 and
Period2, and also increased glutamate uptake. However, while
cultured astroglia show high amplitude circadian rhythms in Period
gene expression, we found no evidence for circadian changes in
Figure 3. Glutamate uptake is not circadian in cultured astrocytes. A, Uptake was measured every 8 h after a full medium exchange in wild
type (black line) or in Clock/Clock (gray line) mouse cortical glia (200 mM tritiated glutamate, n=3 cultures per time point; mean6SEM). B, Glutamate
uptake depended on glutamate concentration, but not circadian time, in rat astrocytes. Dose-response curves were generated every 8 h after a full
medium exchange. Neither the maximal uptake velocity (Vmax) nor the concentration for half-maximal uptake (Km) varied with time of day (n=3
cultures per time point at each glutamate concentration; mean6SEM).
doi:10.1371/journal.pone.0007476.g003
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glutamate reuptake in mouse cortical slices. This provides the first
demonstration of a non-circadian role for clock genes in glial
physiology. We conclude that, while it can be dynamically
modulated by clock gene expression, glutamate uptake by cultured
astroglia is not circadian.
Figure 5. B27 or dB-cAMP as culture supplements do not induce a circadian rhythm in glutamate uptake. A, Uptake was measured in
rat cortical astrocytes with (black line) or without B27 supplements (gray line) (500 mM tritiated glutamate, n=3 cultures per time point; mean6SEM).
B, A 10-day treatment of rat astrocytes with dB-cAMP (250 mM, black line) significantly increased overall glutamate uptake (500 mM tritiated
glutamate), but did not induce circadian rhythmicity (n=3 cultures per time point; mean6SEM).
doi:10.1371/journal.pone.0007476.g005
Figure 4. Circadian gene expression in astrocytes is modulated by culture conditions in vitro.A , Bioluminescence traces from rat Per1::luc
cortical astrocytes. Supplementing the medium with B27 significantly increased Per1-driven bioluminescence levels and circadian rhythm amplitude
(average of 2 cultures per traces). B, Bioluminescence traces from mouse PER2::LUC cortical glia showing higher bioluminescence levels and
amplitude in the presence of B27 (average of 2 cultures per traces). C, Bioluminescence traces from rat cortical astrocytes showing that a 10-day
treatment with dB-cAMP (250 mM) significantly increased Per1-driven bioluminescence levels and rhythm amplitude (average of 2 cultures per traces).
D, Representative photomicrographs of GLAST immunofluorescence showing stellation of rat astrocytes induced by 250 mM dB-cAMP.
Magnification=106.
doi:10.1371/journal.pone.0007476.g004
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glutamate uptake? We found that glutamate uptake was reduced
in glia homozygous for the Clock mutation or the NPAS2 null
mutation, indicating that their gene products augment glutamate
uptake. Both CLOCK and NPAS2 have been shown to dimerize
with BMAL1 protein to transcriptionally activate genes with E-box
sequences in their promoter, such as Per2 [12,24,25]. Thus,
CLOCK or NPAS2 could increase glutamate uptake by activating
transcription of genes involved in glutamate uptake. One
candidate target gene would be Glast, the major transporter of
glutamate in cultured astrocytes. Although the Glast promoter does
not contain the canonical E-box associated with CLOCK/
BMAL1 regulation [16], we found reduced Glast mRNA and
protein levels in Clock/Clock and NPAS22/2 astroglia. CLOCK
and NPAS2 could regulate Glast transcription indirectly, or
GLAST protein stability or localization, events implicated in
GLAST-mediated glutamate uptake [26]. Alternatively, the PER2
protein could be responsible for the regulation of GLAST and
glutamate uptake. In this case, mutations in CLOCK and/or
NPAS2 would reduce PER2 levels and decrease glutamate uptake.
Importantly, there is no evidence for circadian modulation of
glutamate uptake or GLAST function in astroglia indicating that
CLOCK, NPAS2 and PER2 are constitutive activators of GLAST
activity.
Clock/Clock mutant animals display several interesting pheno-
types in addition to overt loss of circadian rhythms in locomotor
activity [8,27]. These include mania-like behaviors [9], obesity
[28,29] and increased dopaminergic and behavioral responses to
cocaine [30]. It is tempting to speculate that reduced glutamate
uptake by astrocytes in Clock/Clock mutants could contribute to
their enhanced locomotor and physiological responses to cocaine,
behaviors and neuroplastic changes in which a glutamatergic
component has been demonstrated [31].
We can not exclude the possibility that the sensitivity of the
assays we used failed to detect a low amplitude circadian rhythm of
glutamate uptake. Supplementing the culture medium with B27 or
dB-cAMP increased glutamate uptake by 13% or 39%, respec-
tively. Importantly, these increases were detectable and significant.
Thus, circadian modulation of glutamate uptake, if it exists, must
be less than a 13% change. Rat astrocytes do show detectable, but
relatively small changes (3–13%) in peak-to-trough Per1-driven
circadian bioluminescence depending on the culture conditions.
Mouse astrocytes showed a 140% change in peak-to-trough PER2
expression, but no detectable rhythm in glutamate uptake. Thus, it
is possible that the amplitude of the oscillation of the circadian
clock in cultured glia does not support rhythms in glutamate
uptake.
It remains an intriguing possibility that glutamate uptake is
circadian in vivo where astrocytes receive signals from other
circadian cell types. It is possible, for example, that neurons
enhance the ability of astrocytes to display circadian rhythms in
glutamate uptake. Without neurons, astrocytes in culture do not
Figure 6. Glutamate uptake in slices of somatosensory cortex is
not circadian. Explants were taken either 2 h before dusk (ZT 10, black
squares) or 2 h before dawn (ZT 23, gray circles) and cultured for 36 h in
vitro until 10-min uptake of 25 mM tritiated glutamate was measured.
White and black bars on top of the X axis represent the projected
subjective day and subjective night, respectively. (n=3 slices per time
point; mean6SEM).
doi:10.1371/journal.pone.0007476.g006
Figure 7. Glutamate uptake in mouse cortical slices is dose
dependent, but not circadian. A–B, Two independent experiments
showing that glutamate uptake is approximately 10 fold higher for a
10 mM glutamate concentration than for a 1 mM concentration. In
addition, glutamate uptake did not show circadian variations at any
concentration (mean6SEM). n=3 for each time and concentration (A),
n=2 for each time and concentration (B).
doi:10.1371/journal.pone.0007476.g007
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is the primary glutamate transporter in cortical astrocytes in vivo
[33,34]. However, we found no rhythms in glutamate uptake in
cortical slices or in glia exposed to dB-cAMP, a treatment that
induces GLT-1 expression and other changes similar to those
produced by adding neurons to the culture [19,32]. We conclude
that the critical role of glutamate clearance by astroglia is not
coupled to their circadian clock, but could be modulated by
circadian signals from other cells.
Materials and Methods
Primary Astrocyte Culture
All procedures were approved by the Animal Care and Use
Committee (Washington University, St Louis) and conformed to
National Institutes of Health guidelines. All efforts were made to
minimize the number of animals used, and their suffering. Unless
otherwise noted, all of the reagents were purchased from Sigma
(St. Louis, MO). We used transgenic Per1::luc rats (Japanese
Wistar; founders a generous gift from Dr. H. Tei, MITILS, Tokyo,
Japan) expressing 6.7 kb of the mouse Per1 promoter driving firefly
luciferase [35], homozygous knock-in mice (congenic on C57Bl/6)
expressing mPeriod2::luciferase (PER2::LUC) fusion protein [36] and
Clock/Clock mutant mice [37] (both founders generous gifts of Dr.
J. Takahashi, Northwestern University, Evanston, IL). We also
used homozygous neuronal PAS domain 2 deficient mice
(NPAS22/2, congenic on C57Bl/6, founders generous gift of
S.L. McKnight, Univ Texas Southwestern, Dallas, TX [24], and
mice with homozygous mutations in both the Per1 and Per2 genes
(mPer1
ldcmPer2
ldc, here referred to as Per1
mPer2
m founders generous
gift of Dr. S.M. Reppert, University of Massachusetts Medical
School, Worcester, MA [14]. We generated Per2
m homozygote
mice by backcrossing Per1
mPer2
m founders with C57Bl/6 to
generate F1 mice heterozygote for both Per1 and Per2. We then
inter-crossed F1 mice to generate F2. Genotype of F2 offspring
was confirmed by PCR and only homozygote Per2
m were used for
cell culture. Cortical glial cultures were generated from neonates
(postnatal days 2–6) following methods published previously
[4,38]. Astrocytes harvested from cultures that had been passaged
between one and three times were plated into 6- or 12-well tissue-
culture plates (glutamate uptake and immunocytochemistry) or
into 35 mm Primaria-treated culture dishes (bioluminescence
recordings, Falcon BD Biosciences, CA). Approximately 6.5610
4
or 1.5610
5 cells were plated per well (12-well and 6-well plates
respectively) and grown until confluence (,7–14 days). Full
medium exchanges were performed twice weekly. In some
experiments, we induced stellation of astrocytes through the
addition of 250 mM dibutyryl cAMP (dB-cAMP) for 10 days. For
all cultures, Time 0 denotes the time when we exchanged the
medium on the day prior to measuring glutamate uptake and
bioluminescence.
Cortical Slice Preparation
Cortical slices were prepared according to the method of Abe et
al (2002) [39] with modifications. Young (15–25 day old)
PER2::LUC mice were anesthetized with CO2 and decapitated
either 1–2 h before lights off (ZT10 group) or before lights on
(ZT23 group). Their brains were dissected and placed in cold
oxygenated HBSS in a vibroslicer. We made 300 mm sections and
collected 2 mm cortical punches from the primary somatosensory
cortex. Cortical punches were placed on a square piece of
Millicell-CM organotypic culture membrane placed on top of a
Millicell insert (Millipore, 0.4 mm pore size, PICM0RG50). The
insert was placed into a 35 mm sterile Petri dish (Falcon BD
Figure 8. Glutamate uptake in rat cortical astrocytes depends
on sodium and a high affinity transporter. A, Glutamate uptake in
sodium-free buffer (LiCl) was significantly lower than in culture medium
with sodium (n=3, mean6SEM). Uptake was initiated with 500 mM
glutamate. B, Trans-2,4-PDC, a high-affinity transporter inhibitor
(100 mM), reduced glutamate uptake (mean6SEM, n=3) by 55–65%.
Uptake was initiated with 1 mM glutamate. C, Glutamate uptake was 18
times higher in cultures immunopositive for GLAST (GLAST+). All cells
which expressed GLAST also expressed GFAP. Separate cultures of cells
immunonegative for GLAST (GLAST-) were also immunonegative for
GFAP and did not uptake glutamate (n=3 cultures per cell type and
concentration, mean6SEM).
doi:10.1371/journal.pone.0007476.g008
Clocks and Glutamate Uptake
PLoS ONE | www.plosone.org 6 October 2009 | Volume 4 | Issue 10 | e7476Biosciences, CA) containing 1 ml of bioluminescence recording
medium (see below). The dishes were sealed with vacuum grease
and cultured for 36 h before glutamate uptake.
Bioluminescence Recording
We monitored bioluminescence as previously published with
slight modifications [4,39]. Per1::luc or PER2::LUC activity was
recorded in 6 min bins with a photomultiplier tube from cortical
glia plated into a Primaria-treated 35 mm Petri dish with 1 ml of
recording medium comprised of DMEM supplemented with 10%
FBS, pen/strep, 10 mM HEPES, 0.35 g/L NaHCO3, 4.5 g/L D-
glucose, 2% L-glutamine, 1x B27 cell culture supplement (Gibco,
Carlsbad, CA) and 0.1 mM beetle luciferin (Promega, Madison,
WI). Bioluminescence was recorded for at least 4 days.
Glutamate Uptake
We performed glutamate uptake on parallel cultures to those
used for bioluminescence recording using published methods [16].
We replaced the recording medium with uptake buffer (5 mM Tris
base, 10 mM HEPES, 140 mM NaCl, 2.5 mM KCl, 1.2 mM
CaCl2, 1.2 mM MgCl2, 1.2 mM K2HPO4, 10 mM Dextrose and
1 mM Methionine Sulfoximine) for 30 min. Methionine Sulfox-
imine was added to inhibit glutamine synthetase activity. After
pre-incubation, we did a full buffer exchange with uptake buffer
supplemented with radioactive glutamate for 10 min at 37uC. For
circadian measurements, we added either 200 mM (mouse
astrocytes) or 500 mM (rat astrocytes) glutamate with 0.25 mCi/
ml of L-[G-3H]glutamate (55 Ci/mmol, GE Healthcare, Pitts-
burgh, PA) and for dose-response measurements, we added 1, 10,
40, 80, 160, 320, 640, or 1280 mM glutamate with 0.4 mCi/ml of
L-[G-3H]glutamate. We terminated uptake with four wash buffer
rinses (identical to uptake buffer except that NaCl was replaced by
140 mM LiCl) in 40 min at 4uC. We lysed the cells immediately
after the fourth wash with 0.1 M NaOH and divided the lysate to
measure glutamate levels by liquid scintillation counting (150–
200 ml cell lysate, Wallac 1410 Liquid Scintillation Counter) and
protein levels by the Bradford Assay (50 ml cell lysate). Sodium-
dependent uptake was assessed in separate rat astrocyte cultures by
replacing NaCl with LiCl in the uptake buffer. We also used L-
trans-Pyrrolidine-2,4-dicarboxylic acid (trans-PDC, 100 mM, Tocris
Bioscience, Ellisville, MO) in the uptake buffer to block glutamate
uptake by high-affinity transporters (1 mM glutamate). We
recorded uptake from triplicate cultures at each time point and
glutamate concentration and reported their mean (6SEM) uptake
velocity normalized to protein content (nmol/min/mg). For
glutamate uptake from cortical punches, circadian time was
estimated from the time of surgery with CT12 defined as the start
of daily locomotor activity in the intact animal. Starting 36 h after
in vitro preparation, cortical punches and their Millicell membrane
were transferred to a 24-well culture plate and incubated for
30 min at 37uC in 300 ml of uptake buffer. We performed
glutamate uptake in cortical punches using the same procedure as
the pure astrocyte culture. We used 300 ml of uptake buffer
containing 1, 10, or 25 mM glutamate with 0.2 mCi L-[G-
3H]glutamate.
Immunocytochemistry
We assessed the purity of replicate astrocyte cultures by double-
immunostaining for the astrocyte-specific marker, glial fibrillary
acidic protein (GFAP), and the high-affinity glutamate transporter,
GLAST. Cells were washed three times in 0.01 M Phosphate
Buffered Saline (PBS), fixed for 30 min in cold 4% paraformal-
dehyde, and washed again 3 times in PBS. Cells were then
permeabilized for 30 min with 0.25% Triton X-100 in PBS
(Triton-PBS) supplemented with 10% bovine serum albumin
(BSA) and then incubated overnight at 4uC in a solution of 0.25%
Triton-PBS with 3% BSA and a combination of a guinea-pig
polyclonal anti-GLAST primary antibody (1:2000 dilution,
Chemicon, Catalog No. AB1782) and a rabbit polyclonal anti-
GFAP antibody (1:1000 dilution, DakoCytomation Denmark,
Code No. Z0334). Astrocytes were then washed three times in
PBS and incubated for 90 min at room temperature with a
combination of a donkey anti-rabbit CY2 and a donkey anti-
guinea-pig CY3 secondary antibody (1:200 dilution for each,
Jackson Immunoresearch, West Grove, PA). Astrocytes were then
washed three times in PBS and cell nuclei were stained with
300 nM 49,6- diamidino-2-phenylindole, dilactate (DAPI, Molec-
ular Probes, Eugene, OR). Fluorescence images were captured
with a Retiga-EX camera (Qimaging, Burnaby, British Columbia,
Canada) at 106magnification (TE200; Nikon, Melville, NY) using
the Northern Eclipse software (Empix Imaging, North Tona-
wanda, NY). We found that immunostaining was absent when the
primary antibodies were omitted. There was also no cross
reactivity between the secondary antibodies. We also compared
GLAST protein expression between Clock/Clock, NPAS22/2,
Per1
mPer2
m homozygous mutants and PER2::LUC homozygous
(or wild-type) astrocytes by quantifying fluorescence as grayscale
intensity (ImageJ software, W.S. Rasband, NIH Bethesda MD,
http://rsb.info.nih.gov/ij/). The grayscale intensity of 6 non-
overlapping fields (106magnification) was measured and divided
by the number of cells present in the field to yield a normalized
fluorescence intensity for each culture. We determined cell density
for each culture from DAPI-labeled nuclei in the same fields as
above.
qRT-PCR- To study the effects of genotype on Glast expression,
we extracted total RNA from Clock/Clock and PER2::LUC
astrocyte cultures 24 h after a full medium exchange (n=2
cultures per genotype, in three separate replicates of each
experiment). To test whether there was a circadian rhythm in
Glast expression, we extracted total RNA from PER2::LUC
astrocytes, starting 24 h after a medium change, every 6 h up to
66 h after medium change (n=2–3 cultures per time point) in
TRIzol according to manufacturer’s instructions (Invitrogen,
Carlsbad, CA). qRT-PCR for Glast and Gapdh was performed
using the Superscript III Platinum SYBR Green One-Step qRT-
PCR Kit (Invitrogen, Carlsbad, CA) with TAQ enzyme and
SYBR Green fluorescent detection according to manufacturer’s
protocol. For each sample, qRT-PCR was performed in triplicate
on 50 ng of total mRNA using the following primers: Glast:
Forward: 59-CTGTTTCGGAATGCCTTCGTT-39, Reverse: 59-
TCACCTCCCGGTAGCTCATTT-39; Gapdh: Forward: 59-
AGCCTCGTCCCGTAGACAAAA-39, Reverse: 59-TGGCAA-
CAATCTCCACTTTGC-39. Glast mRNA was normalized to
Gapdh mRNA abundance. Mean (6SEM) fold change in Glast
expression for Clock/Clock astrocytes was calculated using the
DDCt (deltadeltaCt) method and expressed as a function of wild-
type values. Mean (6SEM) fold change in Glast expression over
time was expressed relative to the first time point.
Data analysis
Glutamate uptake was analyzed by two-way analysis of variance
(ANOVA) with medium composition and time since medium
change as the independent variables. Maximal uptake velocity
(Vmax) and concentration yielding half-maximal uptake (Km) for
dose-response curves were determined by vertical nonlinear least
squares (v-NLLS) regressions using LMMpro software (Alfisol
LCC, C.P. Schulthess, University of Connecticut). Biolumines-
cence amplitude and rhythmicity were analyzed as described
Clocks and Glutamate Uptake
PLoS ONE | www.plosone.org 7 October 2009 | Volume 4 | Issue 10 | e7476previously [4,39]. Detrended bioluminescence was adjusted to the
raw value of the first peak for each culture to compare
bioluminescence levels and amplitude between different culture
conditions. We measured mean bioluminescence levels for the
second 24 h portion of the recording.
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